These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27104862)

  • 1. Potential new drug treatments for congestive heart failure.
    Tran HA; Lin F; Greenberg BH
    Expert Opin Investig Drugs; 2016 Jul; 25(7):811-26. PubMed ID: 27104862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Therapies for Acute and Chronic Heart Failure: Hope or Hype?
    Hanigan S; DiDomenico RJ
    J Pharm Pract; 2016 Feb; 29(1):46-57. PubMed ID: 26759311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving therapies for the management of chronic and acute decompensated heart failure.
    Cook JC; Tran RH; Patterson JH; Rodgers JE
    Am J Health Syst Pharm; 2016 Nov; 73(21):1745-1754. PubMed ID: 27769970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serelaxin : a potential new drug for the treatment of acute heart failure.
    Neverova N; Teerlink JR
    Expert Opin Investig Drugs; 2014 Jul; 23(7):1017-26. PubMed ID: 24865798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serelaxin in acute heart failure: Most recent update on clinical and preclinical evidence.
    Ghosh RK; Banerjee K; Tummala R; Ball S; Ravakhah K; Gupta A
    Cardiovasc Ther; 2017 Feb; 35(1):55-63. PubMed ID: 27727514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ivabradine for treatment of heart failure.
    Bocchi EA; Salemi VMC
    Expert Opin Drug Saf; 2019 May; 18(5):393-402. PubMed ID: 31074301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging drug therapies for the management of acute decompensated heart failure.
    Tunuguntla A
    Tenn Med; 2007 Nov; 100(11):33-7. PubMed ID: 18072692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and emerging pharmacologic options for the management of patients with chronic and acute decompensated heart failure.
    Krzysztofik J; Ponikowski P
    Expert Rev Clin Pharmacol; 2017 May; 10(5):517-534. PubMed ID: 28358228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New drugs for the treatment of chronic heart failure with a reduced ejection fraction: What the future may hold.
    Sciatti E; Dallapellegrina L; Metra M; Lombardi CM
    J Cardiovasc Med (Hagerstown); 2019 Oct; 20(10):650-659. PubMed ID: 31397687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapies in acute and chronic heart failure.
    Aronson D; Krum H
    Pharmacol Ther; 2012 Jul; 135(1):1-17. PubMed ID: 22475446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial.
    Sato N; Lam CS; Teerlink JR; Greenberg BH; Tsutsui H; Oh BH; Zhang J; Lefkowitz M; Hua TA; Holbro T; Marshood M; Wang XL; Ge J
    J Card Fail; 2017 Jan; 23(1):63-71. PubMed ID: 27825893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis.
    Pagnesi M; Baldetti L; Aimo A; Inciardi RM; Tomasoni D; Vizzardi E; Vergaro G; Emdin M; Lombardi CM
    J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in the pharmacotherapeutic management of heart failure in elderly patients: concerns and considerations.
    Screever EM; Meijers WC; van Veldhuisen DJ; de Boer RA
    Expert Opin Pharmacother; 2017 May; 18(7):645-655. PubMed ID: 28375036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newest additions to heart failure treatment.
    Orso F; Fabbri G; Baldasseroni S; Maggioni AP
    Expert Opin Pharmacother; 2014 Sep; 15(13):1849-61. PubMed ID: 24989872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit-risk review of different drug classes used in chronic heart failure.
    Andries G; Yandrapalli S; Aronow WS
    Expert Opin Drug Saf; 2019 Jan; 18(1):37-49. PubMed ID: 30114943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic heart failure: what does the horizon look like?
    Estep JD
    Curr Opin Cardiol; 2015 Jul; 30(4):344-53. PubMed ID: 26049379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newer drugs for heart failure: hype or hope?
    Ghali JK
    Expert Opin Investig Drugs; 2017 Jan; 26(1):5-7. PubMed ID: 27828719
    [No Abstract]   [Full Text] [Related]  

  • 18. Current drugs and medical treatment algorithms in the management of acute decompensated heart failure.
    Triposkiadis F; Parissis JT; Starling RC; Skoularigis J; Louridas G
    Expert Opin Investig Drugs; 2009 Jun; 18(6):695-707. PubMed ID: 19426120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical treatment of heart failure with reduced ejection fraction: the dawn of a new era of personalized treatment?
    Ameri P; Bertero E; Maack C; Teerlink JR; Rosano G; Metra M
    Eur Heart J Cardiovasc Pharmacother; 2021 Nov; 7(6):539-546. PubMed ID: 34037742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serelaxin and acute heart failure.
    Tietjens J; Teerlink JR
    Heart; 2016 Jan; 102(2):95-9. PubMed ID: 26603680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.